Andreas Evers

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Merck KGaA, Darmstadt (Germany)14.5%
• Sanofi (Germany)13.9%
• Eli Lilly (United States)9.4%
• University of Copenhagen8.2%
• Sanofi (France)6.2%
• Helmholtz Zentrum München5.6%
• Other42.4%

Fields

• Medicine37.6%
• Computer Science32.3%
• Biochemistry, Genetics and Molecular Biology22.1%
• Neuroscience2.1%
• Immunology and Microbiology2%
• Pharmacology, Toxicology and Pharmaceutics1.1%
• Other2.9%

Topics

• Computational Drug Discovery Methods24.2%
• Receptor Mechanisms and Signaling11.8%
• Diabetes Treatment and Management11.5%
• Monoclonal and Polyclonal Antibodies Research8.8%
• Neuropeptides and Animal Physiology6.6%
• Protein Structure and Dynamics6.1%
• Other31.1%